tiprankstipranks
Pelthos Therapeutics (PTHS)
:PTHS
US Market
Want to see PTHS full AI Analyst Report?

Pelthos Therapeutics (PTHS) Ownership - Who Owns Pelthos Therapeutics?

74 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
May 26, 2026
xxxxxxxxxxxxx
$40260
Nov 26, 2025
xxxxxxxxxxxxx
$280261
Jul 03, 2025
xxxxxxxxxxxxx
$15000000
Jul 03, 2025
xxxxxxxxxxxxx
$800000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,502,917Insider43.24%39,526,717
1,500,000Insider43.16%39,450,000
203,955Insider5.87%5,364,017
94,192Institution2.71%2,477,250
91,004Institution2.62%2,393,405
40,841Insider1.18%1,074,118
28,462Insider0.82%748,551
24,681Insider0.71%649,110
15,150Insider0.44%398,445
12,000Insider0.35%315,600

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
91,004Institution2.62%2,393,405
10,835Institution0.31%284,961
2,089Institution0.06%54,941

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
78,008Institution2.24%1,950,200
16,184Institution0.47%404,600

FAQ

Who Owns Pelthos Therapeutics (PTHS)?
Currently, no data Available
What percentage of Pelthos Therapeutics (PTHS) stock is held by institutional investors?
Currently, no data Available
What percentage of Pelthos Therapeutics (PTHS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Pelthos Therapeutics (PTHS)?
Todd Davis owns the most shares of Pelthos Therapeutics (PTHS).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.